Showing results (31-40 of 88) with videos related to
Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomasMehdi Hamadani, Don M Benson, Craig C Hofmeister, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 21, 2008
Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing scheduleMitch A Phelps, Darlene M Rozewski, Jeffrey S Johnston, et al.Blood|November 25, 2003
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cellsAndrew P Mone, Peng Huang, Helene Pelicano, et al.British Journal of Haematology|October 24, 2007
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaAmy J Johnson, Amy J Wagner, Carolyn M Cheney, et al.Blood|June 26, 2004
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemiaThomas S Lin, Ian W Flinn, Rama Modali, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantationMehdi Hamadani, Craig C Hofmeister, Buffy Jansak, et al.Leukemia & Lymphoma|October 29, 2009
Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemiaThomas S Lin, Louie Naumovski, Philip S Lecane, et al.JCO Oncology Practice|February 9, 2023
Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion CentersScott A Soefje, Corinne Carpenter, Katherine Carlson, et al.Blood|January 14, 2011
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphomaLapo Alinari, Bo Yu, Beth A Christian, et al.Cancer|March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalJonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.Pageof 9